Intramuscular injection bypasses the medication's intended absorption pathway, causes acute pain, and may lead to unpredictable drug levels or reduced efficacy
For patients and clinicians planning a broader therapy pathway, product references like Wegovy and class comparisons such as Tirzepatide vs Semaglutide offer dosing and mechanism details that inform monitoring
Keytruda: The Pending $100 Billion Question Mercks pembrolizumab product Keytruda (pembrolizumab) is currently the worlds best-selling drug, generating $20.9 billion in 2023 global revenues [14]
Ischemic edema is a significant manifestation of ischemic stroke
While headlines often focus on blockbuster drug approvals or updated clinical guidelines (e.g., screening recommendations), GLP-1s, which were theorized in 1906 and invented in 1986, demonstrate the potential magnitude of shifts in care delivery from a single therapeutic, which has important implications for provider financial viability, patient safety and access to care
Drug levels spike and crash rather than maintaining a consistent therapeutic level